Table 1 Participant characteristics
From: Development and validation of the Newcastle laryngeal hypersensitivity questionnaire
Characteristic | Group 1: Discriminant analysis | Group 2: Responsiveness |
|---|---|---|
N = 38 | N = 44 | |
Age M (SD) | 56.11 (12.4) | 60.4 (13.2) |
Gender (% female) | 77 | 73 |
Dominant Symptom* | Cough 19 (54%) | Cough 38 (86%) |
Breathing 8 (23%) | Breathing 4 (9%) | |
Globus/swallow 2 (5%) | ||
Globus/swallow 5 (14%) | ||
Smoking | Yes 4 (11%) | No 44 (100%) |
No 28 (80%) | ||
Passive 3 (9%) | ||
Associated medical conditions/previous medical history** | Reflux: 17 (49%); Asthma:10 (29%); Rhinitis: 6 (17%); History of psychiatric disorder: 5 (14%); Obstructive Sleep Apnoea: 4 (11%); unrelated comorbidities: 13 (34%). | Reflux: 9 (21%); Asthma: 12 (27%); Rhinitis: 12 (27%); History of psychiatric disorder: 9 (21%); Bronchiectasis: 1 (2%); unrelated comorbidities: 5 (11) |
Other treatment | Asthma treatment (inhaled bronchodilators or inhaled corticosteroids): 17 (49%); Proton pump inhibitor: 19 (54%); Antihistamines: (3%); Nasal/sinus treatment: 5 (14%); Antibiotics: (11%); Continuous Positive Airway Pressure: 1 (3%); Lifestyle changes for reflux: 1 (3%). | Asthma treatment 12 (27%); Proton pump inhibitor 12 (27%); antihistamines 12 (27%) |